Clinical-stage biotech company developing vaccines and
immunotherapies eliciting powerful CD8+ T Cells immune response
COMPANY
ABOUT US
EXECUTIVE COMMITTEE
SCIENTIFIC ADVISORY BOARD
CLINICAL ADVISORY BOARD
BOARD OF DIRECTORS
PARTNERS
SCIENCE
PIPELINE
OVERVIEW
INFLUENZA - OVX836
CORONAVIRUS
NEWS
PRESS RELEASES
MEDIA COVERAGE
PUBLICATIONS
EVENTS
CONTACT
LEGAL MENTIONS
COMPANY
ABOUT US
EXECUTIVE COMMITTEE
SCIENTIFIC ADVISORY BOARD
CLINICAL ADVISORY BOARD
BOARD OF DIRECTORS
PARTNERS
SCIENCE
PIPELINE
OVERVIEW
INFLUENZA - OVX836
CORONAVIRUS
NEWS
PRESS RELEASES
MEDIA COVERAGE
PUBLICATIONS
EVENTS
CONTACT
LEGAL MENTIONS